1-3 of 3
Juan Labardini, MD
Close
Sort by
Journal Articles

Molecular Screening of 28 Genes in Mexican Patients with Acute Myeloid Leukemia a Series of 70 Patients from the Instituto Nacional De Cancerologia, Mexico

Nidia Zapata, MD, Espinoza Ramiro, III, Eduardo Cervera, Judith Cruz, MD, Diana Arcos, MD, Juan Labardini, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5197.
https://doi.org/10.1182/blood-2018-99-115300
Published: 2018
Journal Articles

Impact Of a Federal Program On  response Rate & Survival, In a Cohort Of Patients With Diffuse Large B- Cell Lymphoma. Analysis In a Single National Reference Institution In Mexico

Myrna Candelaria, MD, PhD, Juan Labardini, MD, PhD, Ana Florencia Ramirez, Alejandro Aviles, MD, Enrique Estrada-Lobato, MD, Abelardo Meneses-Garcia, Md, PhD, Alejandro Mohar, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5608.
https://doi.org/10.1182/blood.V122.21.5608.5608
Published: 2013
Journal Articles

Imatinib Alone (IA) Vs. Imatinib + Ara-C (IMAC): A Randomized Phase III Clinical Trial for the Treatment of Early Phase (EP) Chronic Myeloid Leukemia (CML) Ph+. Preliminary Report of Mexican Cooperative Leukemia Group (GRUMELA).

Rafael Hurtado Monroy, MD, Pablo Vargas-Viveros, MD, Eduardo Cervera, MD, Myrna Candelaria, MD, Alvaro Aguayo, MD, Emma Gallardo, MD, Eucario Leon, MD, Juan Labardini, MD, Ricardo Sosa, MD, Rogelio Paredes, MD, Fernando Romero, MD, Oscar Perez, MD, Omar Coronel-Ayala, MD
Journal: Blood
Blood (2004) 104 (11): 1015.
https://doi.org/10.1182/blood.V104.11.1015.1015
Published: 2004